NCT02043366View on ClinicalTrials.gov

Effect of Butorphanol Combined With Flurbiprofen Axetil on Preventing Hyperalgesia Induced by Remifentanil in Patients

NACompletedINTERVENTIONAL

Enrollment

180

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

August 31, 2015

Conditions

PainAnesthesia

Interventions

DRUG

Normal Saline

Normal Saline is intravenously administrated before anesthesia induction

DRUG

Butorphanol

Butorphanol is intravenously administrated

DRUG

Flurbiprofen axetil

Flurbiprofen axetil is intravenously administrated

DRUG

Remifentanil

Remifentanil is intravenously administrated

DRUG

Sufentanil

Sufentanil is intravenously administrated

Trial Locations (1)

300052

Tianjin Medical University General Hospital, Tianjin

All Listed Sponsors

lead

Tianjin Medical University General Hospital

OTHER

NCT02043366 - Effect of Butorphanol Combined With Flurbiprofen Axetil on Preventing Hyperalgesia Induced by Remifentanil in Patients | Biotech Hunter | Biotech Hunter